Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Annals of Thoracic Surgery: The First 50 Years.

The Annals of thoracic surgery·2015
Same author

The last volume of the first half century.

The Annals of thoracic surgery·2014
Same author

The 50th anniversary of the Society of Thoracic Surgeons.

The Annals of thoracic surgery·2014
Same author

The Annals of Thoracic Surgery.

The Annals of thoracic surgery·2014
Same author

Benson Bertheau Roe, Md, July 7, 1918-August 6, 2012.

The Annals of thoracic surgery·2013
Same author

Journal cancer.

The Annals of thoracic surgery·2011

Related Experiment Video

Updated: Jun 16, 2026

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model
06:16

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model

Published on: April 19, 2024

Managing fibrinolysis without aprotinin.

L Henry Edmunds1

  • 1Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-3325, USA. hank.edmunds@uphs.upenn.edu

The Annals of Thoracic Surgery
|January 28, 2010
PubMed
Summary

Cardiopulmonary bypass causes bleeding disorders due to thrombin and fibrinolysis. Current antifibrinolytic drugs are often ineffective, suggesting protocol changes are key for managing bleeding.

Area of Science:

  • Cardiovascular Surgery
  • Hematology
  • Anesthesiology

Background:

  • Cardiopulmonary bypass (CPB) is associated with increased perioperative bleeding.
  • CPB can lead to consumptive coagulopathy, characterized by simultaneous thrombin and fibrinolysis.
  • Bleeding complications are particularly challenging in complex surgical cases.

Purpose of the Study:

  • To review the mechanisms of bleeding associated with CPB.
  • To evaluate current treatment protocols for managing coagulopathy during CPB.
  • To determine optimal strategies for controlling bleeding in complex surgical procedures.

Main Methods:

  • Review of existing literature on CPB-induced coagulopathy.
  • Analysis of mechanisms of thrombin formation and fibrinolysis during CPB.

More Related Videos

Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus
06:45

Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus

Published on: June 2, 2023

Related Experiment Videos

Last Updated: Jun 16, 2026

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model
06:16

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model

Published on: April 19, 2024

Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus
06:45

Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus

Published on: June 2, 2023

  • Evaluation of the efficacy of current antifibrinolytic agents (aprotinin, lysine analogs).

    • Main Results:

    • Thrombin formation and fibrinolysis are prominent in the surgical wound during CPB, peaking at protamine reversal.
    • Aprotinin and lysine analogs show limited success in controlling bleeding in complex surgeries, reoperations, aortic resections, and mechanical circulatory device implantations.
    • Existing treatments may not adequately address the complex bleeding mechanisms in high-risk patients.

    Conclusions:

    • Changes in treatment protocols, rather than solely relying on specific antifibrinolytic drugs, may offer improved bleeding control.
    • Optimizing CPB management and hemostatic strategies is crucial for reducing perioperative bleeding.
    • Further research into tailored treatment protocols is warranted for complex CPB cases.